Vendor review
LN Peptides reviews
LN Peptides reviews from 42 independent lab tests (Tirzepatide, Retatrutide and Tesamorelin): grade A, purity and fill accuracy. Is LN Peptides legit? See what its vials showed.
What the lab tests show
42 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Sep 18, 2026 | Tesamorelin | 99.9 % | 8.51 mg of 10 mg (-15 %) | Pass | View |
| Sep 15, 2026 | Retatrutide | 99.9 % | 18 mg of 20 mg (-10 %) | Pass | View |
| Aug 3, 2026 | Retatrutide | 99.9 % | 32.2 mg of 40 mg (-20 %) | Pass | View |
| Jul 22, 2026 | Retatrutide | 30 mg | Fail | View | |
| Jun 15, 2026 | Tesamorelin | 10 mg | Fail | View | |
| Jun 4, 2026 | Retatrutide | 99.7 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Jun 1, 2026 | Retatrutide | 99.9 % | 12.1 mg of 20 mg (-40 %) | Pass | View |
| May 13, 2026 | Retatrutide | 99.9 % | 9.95 mg of 10 mg (-1 %) | Pass | View |
| Apr 28, 2026 | Tirzepatide | 99.5 % | 12.3 mg of 60 mg (-80 %) | Pass | View |
| Mar 6, 2026 | Tesamorelin | 99.9 % | 8.43 mg of 10 mg (-16 %) | Pass | View |
| Mar 6, 2026 | Tesamorelin | 99.9 % | 8.01 mg of 10 mg (-20 %) | Pass | View |
| Mar 2, 2026 | Tesamorelin | 98.47 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| Feb 26, 2026 | Tesamorelin | 99.72 % | 11.5 mg of 10 mg (15 %) | Pass | View |
| Feb 26, 2026 | Tesamorelin | 98.88 % | 22.8 mg of 20 mg (14 %) | Pass | View |
| Feb 20, 2026 | Retatrutide | 99.7 % | 11.3 mg of 10 mg (13 %) | Pass | View |
| Feb 20, 2026 | Tirzepatide | 99.73 % | 35.2 mg of 40 mg (-12 %) | Pass | View |
| Feb 18, 2026 | Tirzepatide | 99.8 % | 88.5 mg of 100 mg (-12 %) | Pass | View |
| Feb 15, 2026 | Retatrutide | 99.8 % | 30 mg of 30 mg (0 %) | Pass | View |
| Feb 15, 2026 | Tirzepatide | 99.8 % | 22.6 mg of 30 mg (-25 %) | Pass | View |
| Feb 11, 2026 | Retatrutide | 99.9 % | 29.7 mg of 30 mg (-1 %) | Pass | View |
| Feb 4, 2026 | GHK-Cu | 98.7 % | 84.2 mg of 100 mg (-16 %) | Pass | View |
| Jan 26, 2026 | Ipamorelin | 99.9 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Jan 26, 2026 | GHK-Cu | 99.9 % | 48.4 mg of 50 mg (-3 %) | Pass | View |
| Jan 19, 2026 | Tirzepatide | 99.95 % | 42 mg of 60 mg (-30 %) | Pass | View |
| Jan 15, 2026 | Retatrutide | 99.8 % | 21.1 mg of 20 mg (6 %) | Pass | View |
| Jan 15, 2026 | Retatrutide | 99.8 % | 16.8 mg of 15 mg (12 %) | Pass | View |
| Jan 15, 2026 | Tirzepatide | 99.8 % | 31.8 mg of 30 mg (6 %) | Pass | View |
| Jan 15, 2026 | Tirzepatide | 99.8 % | 24 mg of 20 mg (20 %) | Pass | View |
| Dec 30, 2025 | Tirzepatide | 99.6 % | 28.8 mg of 30 mg (-4 %) | Pass | View |
| Dec 17, 2025 | Tirzepatide | 99.82 % | 30.2 mg of 30 mg (1 %) | Pass | View |
| Dec 17, 2025 | Tirzepatide | 99.74 % | 17.8 mg of 20 mg (-11 %) | Pass | View |
| Dec 17, 2025 | Tirzepatide | 99.81 % | 30.4 mg of 30 mg (1 %) | Pass | View |
| Dec 6, 2025 | Tesamorelin | 20 mg | Fail | View | |
| Dec 5, 2025 | Retatrutide | 99.7 % | 42.1 mg of 50 mg (-16 %) | Pass | View |
| Nov 25, 2025 | Tesamorelin | 49.12 % | 5.54 mg of 10 mg (-45 %) | Pass | View |
| Nov 25, 2025 | Tirzepatide | 98.79 % | 56.7 mg of 60 mg (-5 %) | Pass | View |
| Nov 17, 2025 | Retatrutide | 99.68 % | 37.7 mg of 40 mg (-6 %) | Pass | View |
| Oct 21, 2025 | Tesamorelin | 95.68 % | 11.2 mg of 10 mg (12 %) | Pass | View |
| Oct 9, 2025 | Mazdutide | 99.69 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Oct 3, 2025 | Tirzepatide | 99.79 % | 32.3 mg of 30 mg (8 %) | Pass | View |
| Oct 3, 2025 | Tirzepatide | 99.95 % | 31.2 mg of 30 mg (4 %) | Pass | View |
| Sep 25, 2025 | Ipamorelin | 99.77 % | 11.3 mg of 10 mg (13 %) | Pass | View |
What LN Peptides sells
No current listings on record.
About LN Peptides
https://t.me/+RoVjUNS4HtUxNmU1